ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 146 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $18,705,000 | +9.4% | 1,183,835 | -12.1% | 0.68% | +1.2% |
| Q1 2018 | $17,095,000 | +3.2% | 1,346,049 | -7.0% | 0.67% | +1.7% |
| Q4 2017 | $16,567,000 | +6.4% | 1,446,865 | +13.9% | 0.66% | +1.5% |
| Q3 2017 | $15,564,000 | +44.2% | 1,270,555 | +34.8% | 0.65% | +37.8% |
| Q2 2017 | $10,794,000 | +24.2% | 942,709 | +125.5% | 0.47% | +18.3% |
| Q1 2017 | $8,694,000 | 0.0% | 417,963 | 0.0% | 0.40% | -3.9% |
| Q4 2016 | $8,694,000 | +45.1% | 417,963 | +74.2% | 0.41% | +23.2% |
| Q2 2016 | $5,990,000 | – | 239,889 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,628,328 | $33,869,000 | 14.72% |
| Foresite Capital Management II, LLC | 995,396 | $20,704,000 | 10.39% |
| Cormorant Asset Management, LP | 1,581,604 | $32,897,000 | 4.43% |
| DAFNA Capital Management LLC | 221,013 | $4,597,000 | 4.04% |
| New Leaf Venture Partners, L.L.C. | 228,428 | $4,751,000 | 3.40% |
| Partner Investment Management, L.P. | 63,571 | $1,322,000 | 1.75% |
| Iguana Healthcare Management, LLC | 140,000 | $2,912,000 | 1.74% |
| PFM Health Sciences, LP | 2,913,951 | $60,610,000 | 1.71% |
| Redmile Group, LLC | 920,550 | $19,147,000 | 1.65% |
| SECTORAL ASSET MANAGEMENT INC | 669,351 | $13,923,000 | 1.54% |